2001
DOI: 10.1590/s0004-282x2001000400018
|View full text |Cite
|
Sign up to set email alerts
|

Amyloidotic muscle pseudohypertrophy: case report

Abstract: The authors report one case of amyloidosis associated with muscular pseudohypertrophy in a 46-year-old woman, who developed weakness, macroglossia and muscle hypertrophy associated with primary systemic amyloidosis. Electromyography showed a myopathic pattern and bilateral carpal tunnel syndrome. The muscle biopsy presented with a type I and II fiber hypertrophy and infiltration of amyloid material in the interstitious space and artery walls. She underwent bone marrow transplantation with stabilization and sub… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
12
0
8

Year Published

2004
2004
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(21 citation statements)
references
References 13 publications
1
12
0
8
Order By: Relevance
“…Autologous hematopoietic stem cell transplantation comprises the mainstay of treatment, with an estimated median survival of 40 months in transplant-eligible patients compared to 18 months in patients not eligible for the procedure; eligibility is determined by the degree of systemic disease and is in itself a favorable prognostic factor [23]. Prolonged remissions and reduction of muscle overgrowth can be achieved with stem cell transplantation [24], although such a gratifying outcome after 10 years of clinical progression is unusual. The rarity of amyloid myopathy precludes large randomized studies for the validation of optimal treatment strategies.…”
Section: Discussionmentioning
confidence: 99%
“…Autologous hematopoietic stem cell transplantation comprises the mainstay of treatment, with an estimated median survival of 40 months in transplant-eligible patients compared to 18 months in patients not eligible for the procedure; eligibility is determined by the degree of systemic disease and is in itself a favorable prognostic factor [23]. Prolonged remissions and reduction of muscle overgrowth can be achieved with stem cell transplantation [24], although such a gratifying outcome after 10 years of clinical progression is unusual. The rarity of amyloid myopathy precludes large randomized studies for the validation of optimal treatment strategies.…”
Section: Discussionmentioning
confidence: 99%
“…Duchenne and Becker muscular dystrophies are common causes of calf pseudohypertrophy. Amyloidosis [31] and limb-girdle T2 imaging cannot distinguish between fatty deposition and edema-like changes. STIR imaging would have been helpful but was not performed in this case.…”
Section: Basic Patterns Of Abnormalitiesmentioning
confidence: 99%
“…Scola et al (2) , em 2001, descreveram um caso de pseudohipertrofia muscular secundária à amiloidose e relataram…”
Section: Discussionunclassified
“…A forma primária apresenta a proteína fibrilar AL, cujos precursores são imunoglobulinas de cadeia leve: κ e λ (2) . Clinicamente, pode apresentar-se com ampla variedade de sinais e sintomas, dependendo dos órgãos acometidos, sendo mais comumente evidenciados proteinúria nefrótica, hepatoesplenomegalia, insuficiência cardíaca congestiva, síndrome do túnel do carpo e macroglossia (3,4) .…”
Section: Introductionunclassified
See 1 more Smart Citation